In the final edition of EAUTV at EAU24 our expert panel discusses Male LUTS. Moderator Prof. Jean-Nicolas Cornu and discussants Prof. Marcus Drake and Prof. Thomas Herrmann cover the distinctions between prostate symptoms and LUTS, storing and voiding issues, and more.
Purpose The purpose of this American Urological Association (AUA) Guideline amendment is to provide a useful reference on the effective evidence-based management of male lower urinary tract symptoms secondary/attributed to BPH (LUTS/BPH). Materials and Methods The Minnesota Evidence Review...
Elterman gets deep! Dr. Dean Elterman, a urologist at the University of Toronto, discussed urination issues in men with prostate cancer, including BPH and overactive bladder. Valuable insights and Q&A session.
Aquablation, a treatment for benign prostatic hyperplasia, has demonstrated positive outcomes with low morbidity in large prostates (>80 mL). A study found significant and sustained improvements in patient symptoms, including a decrease in International Prostate Symptom Score and an increase in...
TAKE HOME MESSAGES #EAU23 #BPH Jean-Nicolas Cornu delivered a brilliant synopsis today of the evolving landscape of surgical solutions under investigation for male #LUTS treatments. #zenflow Zenflow, Inc. #ProVee ProVerum #FloStent Rivermark Medical, Inc. #optilume Urotronic, Inc. #Aquablation...
PCRI's Alex asks Mark Scholz, MD about urinary symptoms and the treatment of BPH using alpha-blockers. She asks about the level of relief a patient can expect from these medications (if they are effective) the potential side effects, and the duration of potential side effects once the medication...
The benign enlargement of the prostate gland is common in men as they age and it sometimes causes lower urinary tract symptoms. There is a panoply of options, medicinal and surgical, for treating BPH to alleviate these symptoms, but not every medication or surgical option works in every person's...
Updates on androgen replacement therapy and lower urinary tract symptoms: a narrative review (2022) Raed M. Al-Zoubi, Mustafa Alwani, Omar M. Aboumarzouk, Mai Elaarag, Ahmad R. Al-Qudimat, Laxmi Ojha & Aksam Yassin ABSTRACT Lower urinary tract symptoms (LUTS) are caused by higher tension at...
UroLift for Treating Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A NICE Medical Technology Guidance Update (2022) Laura Knight · Megan Dale · Andrew Cleves · Charlotte Pelekanou · Rhys Morris Abstract Lower urinary tract symptoms (LUTS) commonly occur as a consequence of...
UPDATE – Canadian Urological Association guideline: Male lower urinary tract symptoms/ benign prostatic hyperplasia (2022) Dean Elterman, Mélanie Aubé-Peterkin, Howard Evans, Hazem Elmansy, Malek Meskawi, Kevin C. Zorn, Naeem Bhojani Introduction The current document summarizes the...
Abstract Purpose of Review Rezum® is a novel convection-based thermal therapy for benign prostatic hyperplasia (BPH) induced lower urinary tract symptoms (LUTS). This review provides an overview of its safety, efficacy, cost, and potential role in the paradigm of BPH/LUTS therapies. Recent...
Abstract Purpose Rezūm is the latest developed minimally invasive treatment for benign prostatic hyperplasia (BPH). We aimed to carefully assess the functional outcomes of patients treated with Rezūm for BPH. Methods We prospectively followed 135 consecutive patients treated by Rezūm at 5...
ABSTRACT Lower urinary tract symptoms (LUTS) are a cluster of voiding symptoms, such as a weak stream, hesitancy, intermittency, urinary frequency, urgency, and nocturia. LUTS are frequent in elderly men and is considered the ultimate clinical symptoms of benign prostatic hyperplasia. With...
Abstract Purpose of Review To explore the sexual outcomes following the novel minimally invasive surgical procedures for benign prostatic hyperplasia- (BPH-) related lower urinary tract symptoms (LUTS), with an emphasis on ejaculatory dysfunction (EjD). Recent Findings A database search with...
The iTind Temporarily Implanted Nitinol Device for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Multicenter, Randomized, Controlled Trial Abstract Objective To report the results of a multicenter, randomized, controlled trial with a temporarily...
Efficacy and Safety of Combination Comprising Tamsulosin and PDE5-Is, Relative to Monotherapies, in Treating Lower Urinary Tract Symptoms and Erectile Dysfunction Associated With Benign Prostatic Hyperplasia: A Meta-Analysis Abstract We report the safety and efficacy of combination therapy...
Purpose: This study aimed to compare the efficacy and safety of combination therapy consisting of a-blockers and different phosphodiesterase type 5 inhibitors for lower urinary tract symptoms (LUTS) by performing a network meta-analysis. Method: Relevant articles were retrieved from the...
Tadalafil Alone or in Combination with Tamsulosin for the Management for LUTS/BPH and ED A. Sebastianelli & P. Spatafora & S. Morselli & L. Vignozzi & S. Serni & K. T. McVary & S. Kaplan & S. Gravas & C. Chapple & Mauro Gacci Abstract Purpose of Review Aim of our systematic review is to...
3-Year results following treatment with the second generation of the temporary implantable nitinol device in men with LUTS secondary to benign prostatic obstruction Abstract Background To report the 3-year results of a prospective, single-arm, multicenter, international clinical study...
Purpose: We aimed to investigate the effect of continuous positive airway pressure (CPAP) administered for the treatment of obstructive upper airway on lower urinary tract symptoms and erectile dysfunction in male patients. Materials and Methods: A total of 626 males with suspected obstructive...
Pharmacological treatment of lower urinary tract symptoms in benign prostatic hyperplasia: consequences on sexual function and possible endocrine effects ABSTRACT Introduction: Benign prostate hyperplasia (BPH) is one of the most prevalent diseases in aging men. It may adversely affect...
Urinary and sexual function after treatment with temporary implantable nitinol device (iTind) in men with LUTS: 6‑month interim results of the MT‑06‑study Abstract Purpose To evaluate the functional outcomes as they relate to the preservation of urinary continence and sexual function...
Purpose Benign prostatic hyperplasia (BPH) is a histologic diagnosis that refers to the proliferation of smooth muscle and epithelial cells within the prostatic transition zone. The prevalence and the severity of lower urinary tract symptoms (LUTS) in the aging male can be progressive and is an...
Abstract: The number of compounds used in the pharmacological treatment of lower urinary tract symptoms (LUTS) of patients who do not respond to conservative measures has been relatively stable during the last decade, with the exception of the introduction of the new class of β3 adrenoceptor...
Abstract Objectives The benign prostatic syndrome, comprising lower urinary tract symptomatology secondary to benign prostatic hyperplasia/enlargement, represents a major health care issue in westernized countries. The pharmacological management involves alpha-adrenoceptor antagonists...
Effect of tadalafil 5 mg on post-micturition dribble in men with lower urinary tract symptoms: a multicentre, double-blind, randomized, placebocontrolled trial Dae Yul Yang*, Hyun Cheol Jeong*, Kyungtae Ko*, Seong Ho Lee† , Sang Kon Lee‡ , Tae Young Shin‡ , Jin Seon Cho§ and Won Ki Lee...
“Aquabeam® System” for benign prostatic hyperplasia and LUTS: birth of a new era. A systematic review of functional and sexual outcomes and adverse events of the technique Reale Giulio● Cimino Sebastiano● Bruno Giorgio● Palmieri Fabiano● Giardina Raimondo● Russo Giorgio Ivan● Grimaldi Enrico●...
Conclusions Diet is an important factor afecting the risk of development of BPH and ED. Several studies have shown the efect of dietary interventions for BPH and ED [39]. A better understanding diet and its relative efects on the development, treatment and prevention of these diseases are an...
Objective impacts of tadalafil on storage and voiding function in male patients with benign prostatic hyperplasia: 1‑year outcomes from a prospective urodynamic study Yoshihisa Matsukawa1 · Shun Takai1 · Tsuyoshi Majima1 · Yasuhito Funahashi1 · Naoto Sassa1 · Masashi Kato1 · Tokunori Yamamoto1...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.